European regulators cast doubt on Biogen Alzheimer’s treatment
EMA vote deals a setback to controversial $56,000-a-year treatment
EMA vote deals a setback to controversial $56,000-a-year treatment
Pharma group resurrects pipeline therapy it abandoned as ineffective earlier this year
Early-stage clinical trial involving aducanumab has yielded promising results
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices